Bevacizumab for pediatric radiation necrosis.
Sign Up to like & getrecommendations! Published in 2020 at "Neuro-oncology practice"
DOI: 10.1093/nop/npz072
Abstract: Background Radiation necrosis is a frequent complication occurring after the treatment of pediatric brain tumors; however, treatment options remain a challenge. Bevacizumab is an anti-VEGF monoclonal antibody that has been shown in small adult cohorts… read more here.
Keywords: symptomatic radiation; bevacizumab pediatric; radiation necrosis; radiation ... See more keywords